Certainty of Evidence for outcome: mortality of Dexamethasone application - Clinical Practice Guidelines (CPG) on EBMonFHIR v1.0.2

Clinical Practice Guidelines (CPG) on EBMonFHIR
1.0.2 - qa-preview

This page is part of the CPG-on-EBMonFHIR Implementation Guide (1.0.2).

Example ArtifactAssessment: Certainty of Evidence for outcome: mortality of Dexamethasone application

Generated Narrative: ArtifactAssessment DexamethasoneRatingOutcomeMortality

ArtifactAssessment Version: v4.0

ArtifactAssessment Publication Status: active

date: 2020-01-03

artifact: Evidence ExampleOutcomeEvidence

content
informationType: Rating
type: Overall certainty
classifier: Moderate quality

content
informationType: Rating
type: Clinical Importance
classifier: Critical

content
informationType: Rating
type: Risk of bias
classifier: serious concern

content
informationType: Rating
type: Inconsistency
classifier: no serious concern

content
informationType: Rating
type: Indirectness
classifier: no serious concern

content
informationType: Rating
type: Imprecision
classifier: no serious concern

content
informationType: Rating
type: Publication bias
classifier: no serious concern